This year has brought a bumper crop of mergers & acquisitions already, and the trend continued in October. However, while the number of announcements grew, acquirers spent less on M&As in aggregate during the month compared to how much they spent in September.
M&A activity in the U.S. still rising
FactSet’s Mergers staff reports that M&A activity in the U.S. increased 1.8% in October month over month, reaching 1,078 deal announcements. Overall spending on those deals declined, however, as those making offers spent 3.1% on their deals in October compared to the month before. Here’s a look at how M&A activities have been shaping up by month over the last couple of years:
Michele Ragazzi's Giano Capital returned 1.9% for March, taking the fund's year-to-date performance to 1.7%. Since its inception, Ragazzi's flagship fund has produced a compound annual return of 7.8%. According to a copy of the €10 million fund's March update, a copy of which ValueWalk has been able to review, Giano's most significant investment at Read More
Commercial Services, Technology Services lead in M&A growth
The firm reports that based on year over year growth for the last three months, the Commercial Services and Technology Services witnessed the largest increases, with the former capturing 517 deals this year compared to 446 last year and the latter taking 548 deals compared to last year’s 501. Health Services was in a distant third place with 162 deals compared to 132 deals last year. According to FactSet Mergerstat, nine of the 21 tracked sectors saw year over year gains in M&As over the last three months.
The three sectors that have witnessed the biggest year over year volume declines over the last three months are Industrial Services, which fell from 141 to 103 this year, Finance, which fell to 403 from 427, and Producer manufacturing, which declined from 2013 to 180. Twelve of the tracked sectors saw year over year declines in M&A deal flow over the last three months adding up to a total decline of 151 deals.
Here’s how M&A activity is shaping up by sector:
Pfizer – Allergan leads in M&A deal size
FactSet reports that the largest deal announced in October was Pfizer’s offer of $149.8 billion to buy Allergan. In a distant second place was the acquisition of EMC Corp. by a group of private buyers led by Dell Founder Michael Dell, MSD Partners, and Silver Lake Management in a deal worth $64.3 billion.
Private equity M&A involvement up slightly
The firm reports that involvement of U.S. private equity firms ticked up a bit during October, increasing by 0.9% month over month. M&A deal volume involving PE firms climbed by one deal to 111, but the aggregate base equity increased, rising 87.4% to $24 billion month over month.
Canada leads buyers of U.S. firms
FactSet also found that the largest buyers of U.S.-based firms during October were Canadian firms with 31 deals. In second place for the most U.S. deals were U.K.-based companies with 27, although U.K. firms were also the biggest sellers to U.S.-based companies with 28. Canada was in second place behind the U.K. in selling to U.S. companies.
The second biggest M&A deal to acquire a U.S. company was the offer made by DSV A/S (based in Denmark) for UTi Worldwide, which was worth $753.1 million. The biggest offer made by a U.S.-based company was Pfizer’s agreement to buy Allergan, which is based in Ireland.
All graphs and charts in this article are courtesy FactSet.